Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.
There are no as such competitors for Actuate Therapeutics.
Actuate Therapeutics has a consensus price target of $17.50.
The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $1.353 last updated July 21, 2026 at 6:20 PM EDT.
There are no upcoming dividends for Actuate Therapeutics.
Actuate Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Actuate Therapeutics.
Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.